Antoine Lewin, Mindy Goldman, Sheila F O'Brien, David O Irving, Ralph Vassallo, Pierre Tiberghien, Naoko Goto, Allison Waters, Thijs van de Laar, Cyril Jacquot, Roberta Fachini, Marc Germain
{"title":"COVID-19大流行之前和期间的献血者特征和血液安全:BEST合作国际调查","authors":"Antoine Lewin, Mindy Goldman, Sheila F O'Brien, David O Irving, Ralph Vassallo, Pierre Tiberghien, Naoko Goto, Allison Waters, Thijs van de Laar, Cyril Jacquot, Roberta Fachini, Marc Germain","doi":"10.1111/vox.70055","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and objectives: </strong>Early in the COVID-19 pandemic, blood suppliers faced unique challenges meeting changing demand while maintaining safety for donors, recipients and staff. Actions taken may have altered the composition of the donor base and the frequency of confirmed-positive infectious disease marker (IDM) rates. No studies have evaluated the impact of the pandemic on donations, donor demographics and blood safety across several countries.</p><p><strong>Materials and methods: </strong>Whole blood/red blood cell (RBC) donors and donations and confirmed IDM reactivity recorded during from 11 March 2019 to 11 September 2019 (\"pre-pandemic period\") and from 11 March 2020 to 11 September 2020 (\"pandemic period\") were collected by 11 blood services participating in the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.</p><p><strong>Results: </strong>Eleven blood services from nine countries reported on over 4 million donations per period. On average, donations dropped by 4.0% between pre-pandemic and pandemic periods, driven by fewer donations from active repeat donors (-5.6%) and first-time [FT] donors (-14.0%) but partially offset by more donations from lapsed donors (+15.7%). The decline was also driven by fewer donations from male donors (-7.6%) and younger donors (i.e., 16-25 years: -19.0%). Overall, the rate of confirmed IDM positivity dropped from 100.0 to 88.6 per 100,000 donors (-11.4%) between pre-pandemic and pandemic periods.</p><p><strong>Conclusion: </strong>Early in the pandemic, blood donations, particularly from FT donors, decreased. In future respiratory virus pandemics, blood banks should anticipate changes in demand, collection site locations and capacity and donor behaviour. Unlike results in acute catastrophes, lower rates of confirmed IDM positivity were observed, in part related to lower numbers of FT, male and younger donors.</p>","PeriodicalId":23631,"journal":{"name":"Vox Sanguinis","volume":" ","pages":"776-783"},"PeriodicalIF":1.6000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Blood donor characteristics and blood safety before and during the COVID-19 pandemic: A BEST Collaborative international survey.\",\"authors\":\"Antoine Lewin, Mindy Goldman, Sheila F O'Brien, David O Irving, Ralph Vassallo, Pierre Tiberghien, Naoko Goto, Allison Waters, Thijs van de Laar, Cyril Jacquot, Roberta Fachini, Marc Germain\",\"doi\":\"10.1111/vox.70055\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background and objectives: </strong>Early in the COVID-19 pandemic, blood suppliers faced unique challenges meeting changing demand while maintaining safety for donors, recipients and staff. Actions taken may have altered the composition of the donor base and the frequency of confirmed-positive infectious disease marker (IDM) rates. No studies have evaluated the impact of the pandemic on donations, donor demographics and blood safety across several countries.</p><p><strong>Materials and methods: </strong>Whole blood/red blood cell (RBC) donors and donations and confirmed IDM reactivity recorded during from 11 March 2019 to 11 September 2019 (\\\"pre-pandemic period\\\") and from 11 March 2020 to 11 September 2020 (\\\"pandemic period\\\") were collected by 11 blood services participating in the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.</p><p><strong>Results: </strong>Eleven blood services from nine countries reported on over 4 million donations per period. On average, donations dropped by 4.0% between pre-pandemic and pandemic periods, driven by fewer donations from active repeat donors (-5.6%) and first-time [FT] donors (-14.0%) but partially offset by more donations from lapsed donors (+15.7%). The decline was also driven by fewer donations from male donors (-7.6%) and younger donors (i.e., 16-25 years: -19.0%). Overall, the rate of confirmed IDM positivity dropped from 100.0 to 88.6 per 100,000 donors (-11.4%) between pre-pandemic and pandemic periods.</p><p><strong>Conclusion: </strong>Early in the pandemic, blood donations, particularly from FT donors, decreased. In future respiratory virus pandemics, blood banks should anticipate changes in demand, collection site locations and capacity and donor behaviour. Unlike results in acute catastrophes, lower rates of confirmed IDM positivity were observed, in part related to lower numbers of FT, male and younger donors.</p>\",\"PeriodicalId\":23631,\"journal\":{\"name\":\"Vox Sanguinis\",\"volume\":\" \",\"pages\":\"776-783\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-08-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vox Sanguinis\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1111/vox.70055\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/6/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vox Sanguinis","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/vox.70055","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/4 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Blood donor characteristics and blood safety before and during the COVID-19 pandemic: A BEST Collaborative international survey.
Background and objectives: Early in the COVID-19 pandemic, blood suppliers faced unique challenges meeting changing demand while maintaining safety for donors, recipients and staff. Actions taken may have altered the composition of the donor base and the frequency of confirmed-positive infectious disease marker (IDM) rates. No studies have evaluated the impact of the pandemic on donations, donor demographics and blood safety across several countries.
Materials and methods: Whole blood/red blood cell (RBC) donors and donations and confirmed IDM reactivity recorded during from 11 March 2019 to 11 September 2019 ("pre-pandemic period") and from 11 March 2020 to 11 September 2020 ("pandemic period") were collected by 11 blood services participating in the Biomedical Excellence for Safer Transfusion (BEST) Collaborative.
Results: Eleven blood services from nine countries reported on over 4 million donations per period. On average, donations dropped by 4.0% between pre-pandemic and pandemic periods, driven by fewer donations from active repeat donors (-5.6%) and first-time [FT] donors (-14.0%) but partially offset by more donations from lapsed donors (+15.7%). The decline was also driven by fewer donations from male donors (-7.6%) and younger donors (i.e., 16-25 years: -19.0%). Overall, the rate of confirmed IDM positivity dropped from 100.0 to 88.6 per 100,000 donors (-11.4%) between pre-pandemic and pandemic periods.
Conclusion: Early in the pandemic, blood donations, particularly from FT donors, decreased. In future respiratory virus pandemics, blood banks should anticipate changes in demand, collection site locations and capacity and donor behaviour. Unlike results in acute catastrophes, lower rates of confirmed IDM positivity were observed, in part related to lower numbers of FT, male and younger donors.
期刊介绍:
Vox Sanguinis reports on important, novel developments in transfusion medicine. Original papers, reviews and international fora are published on all aspects of blood transfusion and tissue transplantation, comprising five main sections:
1) Transfusion - Transmitted Disease and its Prevention:
Identification and epidemiology of infectious agents transmissible by blood;
Bacterial contamination of blood components;
Donor recruitment and selection methods;
Pathogen inactivation.
2) Blood Component Collection and Production:
Blood collection methods and devices (including apheresis);
Plasma fractionation techniques and plasma derivatives;
Preparation of labile blood components;
Inventory management;
Hematopoietic progenitor cell collection and storage;
Collection and storage of tissues;
Quality management and good manufacturing practice;
Automation and information technology.
3) Transfusion Medicine and New Therapies:
Transfusion thresholds and audits;
Haemovigilance;
Clinical trials regarding appropriate haemotherapy;
Non-infectious adverse affects of transfusion;
Therapeutic apheresis;
Support of transplant patients;
Gene therapy and immunotherapy.
4) Immunohaematology and Immunogenetics:
Autoimmunity in haematology;
Alloimmunity of blood;
Pre-transfusion testing;
Immunodiagnostics;
Immunobiology;
Complement in immunohaematology;
Blood typing reagents;
Genetic markers of blood cells and serum proteins: polymorphisms and function;
Genetic markers and disease;
Parentage testing and forensic immunohaematology.
5) Cellular Therapy:
Cell-based therapies;
Stem cell sources;
Stem cell processing and storage;
Stem cell products;
Stem cell plasticity;
Regenerative medicine with cells;
Cellular immunotherapy;
Molecular therapy;
Gene therapy.